|
Aweeka, F T; Hu, C; Huang, L et al. (2015) Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics. HIV Med 16:176-83
|
|
Weinberg, Adriana; Dickover, Ruth; Britto, Paula et al. (2008) Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy. AIDS 22:2267-77
|
|
Read, J S; Best, B M; Stek, A M et al. (2008) Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum. HIV Med 9:875-82
|
|
Mirochnick, Mark; Best, Brookie M; Stek, Alice M et al. (2008) Lopinavir exposure with an increased dose during pregnancy. J Acquir Immune Defic Syndr 49:485-91
|
|
Sharma, Tanvi S; Hughes, Jane; Murillo, Amarylis et al. (2008) CD8+ T-cell interleukin-7 receptor alpha expression as a potential indicator of disease status in HIV-infected children. PLoS One 3:e3986
|
|
McKinney Jr, Ross E; Rodman, John; Hu, Chengcheng et al. (2007) Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021. Pediatrics 120:e416-23
|
|
Stek, Alice M; Mirochnick, Mark; Capparelli, Edmund et al. (2006) Reduced lopinavir exposure during pregnancy. AIDS 20:1931-9
|
|
Tuomala, Ruth E; Shapiro, David E; Mofenson, Lynne M et al. (2002) Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 346:1863-70
|
|
Laufer, M; Scott, G B (2000) Medical management of HIV disease in children. Pediatr Clin North Am 47:127-53
|
|
Geffin, R B; Scott, G B; Melenwick, M et al. (1998) Association of antibody reactivity to ELDKWA, a glycoprotein 41 neutralization epitope, with disease progression in children perinatally infected with HIV type 1. AIDS Res Hum Retroviruses 14:579-90
|
Showing the most recent 10 out of 15 publications
